Amyloid PET imaging in cardiac amyloidosis: a pilot study using 18F-flutemetamol positron emission tomography

被引:0
作者
Sebastien Dietemann
René Nkoulou
机构
[1] Geneva University and University Hospitals of Geneva,Department of Nuclear Medicine
[2] University Hospitals of Geneva,Division of Cardiology
来源
Annals of Nuclear Medicine | 2019年 / 33卷
关键词
F-flutemetamol; PET; Cardiac amyloidosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:624 / 628
页数:4
相关论文
共 84 条
[1]  
Merlini G(2003)Molecular mechanisms of amyloidosis N Engl J Med 349 583-596
[2]  
Bellotti V(2010)Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis JACC Cardiovasc Imaging 3 155-164
[3]  
Syed IS(2016)Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis Cardiovasc Pathol 25 413-417
[4]  
Glockner JF(2011)Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis JACC Cardiovasc Imaging 4 659-670
[5]  
Feng D(2008)Usefulness of 99mTc-DPD scintigraphy in cardiac amyloidosis J Am Coll Cardiol 51 1509-1510
[6]  
Araoz PA(2018)Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis Eur J Nucl Med Mol Imaging 45 1945-1955
[7]  
Martinez MW(2018)Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR) J Nucl Cardiol 25 240-248
[8]  
Edwards WD(2015)C-Pittsburgh B PET imaging in cardiac amyloidosis JACC Cardiovasc Imaging 8 50-59
[9]  
Stats MA(2014)Is Clin Nucl Med 39 747-749
[10]  
Stone JR(2015)F-flutemetamol PET/CT able to reveal cardiac amyloidosis? Front Cardiovasc Med 8 23-1662